Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidated Statements of Stockholders' Equity (Unaudited)

v3.22.1
Condensed Consolidated Statements of Stockholders' Equity (Unaudited) - USD ($)
$ in Thousands
Total
Revision of Prior Period, Accounting Standards Update, Adjustment
Common Stock
Additional Paid-in Capital
Additional Paid-in Capital
Revision of Prior Period, Accounting Standards Update, Adjustment
Accumulated Deficit
Beginning balance (in shares) at Dec. 31, 2020     17,047,584      
Beginning balance at Dec. 31, 2020 $ 2,377 $ (3,107) $ 170 $ 121,729 $ (3,107) $ (119,522)
Issuances of common stock:            
Public offering of common stock (in shares)     2,127,660      
Public offering of common stock 46,785   $ 21 46,764    
Share-based compensation (in shares)     20,709      
Share-based compensation 320   $ 1 319    
Warrant and option exercises (cash and cashless) (in shares)     1,482,327      
Warrant and option exercises (cash and cashless) 145   $ 15 130    
Net Income (Loss) Attributable to Parent (2,538)         (2,538)
Ending balance (in shares) at Mar. 31, 2021     20,678,280      
Ending balance at Mar. 31, 2021 43,982   $ 207 165,835   (122,060)
Beginning balance (in shares) at Dec. 31, 2021     23,665,991      
Beginning balance at Dec. 31, 2021 48,787   $ 237 182,482   (133,932)
Issuances of common stock:            
Share-based compensation (in shares)     29,916      
Share-based compensation 899     899    
Warrant and option exercises (cash and cashless) (in shares)     12,211      
Warrant and option exercises (cash and cashless) 3     3    
Net Income (Loss) Attributable to Parent (3,959)         (3,959)
Ending balance (in shares) at Mar. 31, 2022     23,708,118      
Ending balance at Mar. 31, 2022 $ 45,730   $ 237 $ 183,384   $ (137,891)